Stand Up To Cancer And Jazz Pharmaceuticals Collaborate To Fund Catalyst Research On Hard-To-Treat…
$4 Million Research Collaboration to Explore New Treatment Options for Pediatric Solid Tumors or RAF, RAS Mutated Tumors
Stand Up To Cancer (SU2C)…